Some of the stocks that may grab investor focus today are:
-
Cintas Corporation (NASDAQ: CTAS) reported weak
earnings for its second quarter. However, the company raised its forecast for fiscal 2017. Cintas shares fell 2.83 percent to
$116.69 in the after-hours trading session.
-
Dipexium Pharmaceuticals Inc. (NASDAQ: DPRX)
announced plans to merge with privately-held PLx Pharma Inc in an all-stock deal. Dipexium Pharmaceuticals shares jumped 65.62
percent to $2.65 in after-hours trading.
-
Cal-Maine Foods Inc (NASDAQ: CALM) posted in-line
loss for its second quarter, but sales missed expectations. Cal-Maine shares rose 0.24 percent to $42.10 in the after-hours
trading session.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
-
Synergy Pharmaceuticals Inc (NASDAQ: SGYP)
announced after Thursday's closing bell that its drug plecanatide, a daily pill to fight irritable bowel syndrome, had achieved
positive top-line results from the second of two pivotal phase 3 clinical trials evaluating the efficacy and safety of the
drug. Synergy Pharmaceuticals shares climbed 11.39 percent to $5.28 in the after-hours trading session.
-
Hennessy Capital Acquisition Corp. II (NASDAQ: HCAC) and Daseke, Inc. disclosed that they have entered into a merger
agreement. Hennessy Capital Acquisition shares rose 0.41 percent to $9.91 in after-hours trading.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.